Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
sex decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
sex decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2321
-
2322
-
2323
-
2324
-
2325
-
2326
-
2327
Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28).
Published 2025“…Expression of 7 proteins significantly correlated with stereotypy severity in CD1 mice. …”
-
2328
Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.
Published 2025Subjects: -
2329
-
2330
-
2331
-
2332
-
2333
Amplitude for A/L = 0.29.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2334
Amplitude for A/L = 0.338.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2335
Amplitude for A/L = 0.02.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2336
Amplitude for A/L = 0.03.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2337
AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves.
Published 2025Subjects: -
2338
-
2339
Comparison in baseline variables between efficacy group and non-efficacy group.
Published 2025Subjects: -
2340